title: The wave of the future: genetic profiling in treatment selection.
abstract: Chemotherapy treatment recommendations traditionally have been based on the anatomic site of origin and the histology of the tumor. More recently, treatment options are transitioning to targeted therapies, in which drug selection is based on mutations present in an individual tumor. Genomic testing is a developing area that involves testing tumors to determine their molecular or genetic characteristics, then matching those characteristics to treatments that specifically target them.
authors.affiliation: Michiana Hematology Oncology's Advanced Centers for Cancer Care, Mishawaka, IN.
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Ewing
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D020869:Gene Expression Profiling; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents
keywords: cancer treatment; chemotherapy; genetics